Patient Care Bio
Director of Anatomic Pathology. An internationally recognized expert in bone biology, osteoporosis, and metabolic bone disease, Dr. Boyce is also a diagnostic surgical pathologist with a sub-specialty interest in bone and soft tissue pathology. He served as Director of Surgical Patholgy from 1999-2007. His research laboratory studies regulatory mechanisms controlling osteoblast and osteoclast function, in particular where there is the potential of opening up new therapeutic pathways for preventing or treating osteoporosis. He was the first to report osteoclast apoptosis in 1996, and has been funded continuously since then to study the osteoclast, which is essential for bone modeling and remodeling and mediates bone loss in common bone diseases, including rheumatoid arthritis and postmenopausal osteoporosis.
| Secretary/Treasurer, American Society for Bone & Mineral Research |
2011 - 2013 |
| Treasurer, United States Biological Stain Commission |
2010 - Present |
| Member, Executive Committee, American Society for Bone & Mineral Research | ASBMR |
2010 - 2013 |
| Secretary/Treasurer-Elect, American Society for Bone & Mineral Research | ASBMR |
2010 - 2011 |
| Chair, Gordon Research Conference on Bones and Teeth |
2009 |
| Treasurer, International Society of Bone Morphometry | ISBM |
2009 - 2012 |
| Vice Chair, Gordon Research Conference on Bone and Teeth |
2007 |
| Young Investigator of Year Award from Amer. Society for Bone & Mineral Research to Dr. Qian Zhang (post-doc fellow in my lab) |
2007 |
| Young Investigator of Year Award from Amer. Society for Bone & Mineral Research to Dr. Qian Zhang (post-doc fellow in my lab) |
2005 |
| Young Investigator of Year Award from International Society of Bone Morphometry to Dr. Zhenqiang Yao (post-doc fellow in my lab) |
2005 |
| Secretary/Treasurer, Association of Osteobiology |
2003 - 2006 |
| President International Society of Bone Morphometry |
2002 - 2006 |
| Council Member Association of Osteobiology |
2001 - 2007 |
| Travel Award From American Society for Bone and Mineral Research to Dr. Lianping Xing from my lab |
2000 |
| Member, Board of Directors International Society of Bone Morphometry |
1999 - Present |
| New Investigator Award From Orthopaedic Research Society to Dr. Lianping Xing (post-doctoral fellow in my lab) |
1999 |
| Travel Award From American Society for Bone and Mineral Research to Dr. Sheela Rani (post-doctoral fellow in my lab) |
1998 |
| Most Outstanding Abstract of Mtg President's Award fr. Amer. Soc Bone & Min Res Drs L Xing, G Franzoso, U Siebenlist & BF Boyce |
1997 |
| Young Investigator of Year Award fr Amer. Society for Bone & Mineral Research to Dr. Lianping Xing (post-doc fellow in my lab) |
1996 |
| Young Investigator of Year Award from Amer. Society for Bone & Mineral Research to Dr. Hong Chen (post-doc fellow in my lab) |
1993 |
| Peel International Research Fellowship (London, England) |
1986 - 1987 |
| Pathological Society Travel Award (London, England) |
1986 - 1987 |
| McCunn Trust Traveling Fellowship (Glasgow, Scotland) |
1986 - 1987 |
| Jean Mackintosh Traveling Research Fellowship (Glasgow, Scotland) |
1977 |
Neutralizing Rat Monoclonal Antibody Specific for Mouse Vascular Endothelial Growth Factor Receptor (VEGFR)-2 (DC101) Reduces Joint Damage in Chronic Inflammatory Arthritis
United States Serial NO.: 12/389,193
Filed Date: February 19, 2009
Title: Methods and Compositions for Treating Inflammatory Conditions
Invented by: Lianping Xing, Brendan Boyce, Edward Schwarz
|
Neutralizing Rat Monoclonal Antibody Specific for Mouse Vascular Endothelial Growth Factor Receptor (VEGFR)-2 (DC101) Reduces Joint Damage in Chronic Inflammatory Arthritis
United States Serial NO.: 14/068,823
Filed Date: October 31, 2013
Title: Methods and Compositions for Treating Inflammatory Conditions
Invented by: Lianping Xing, Brendan Boyce, Edward Schwarz
|
TRAF3 Protein Levels in Peripheral Blood Monocytes Predict which Patients with Rheumatoid Arthritis and Psoriatic Arthritis will Respond to Anti-TNF Therapy
United States Serial NO.: 14/761,408
Filed Date: January 10, 2014
Title: Method to Identify Patients That Will Likely Respond to Anti-TNF Therapy
Invented by: Brendan Boyce, Lianping Xing, Christopher Ritchlin, Yan Xiu
|
